Graf Akcie CGIX (Cancer Genetics Inc.). Diskuze k akciím CGIX. Aktuální informace CGIX.

Základní informace o společnosti Cancer Genetics Inc. (Akcie CGIX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 48.69M
Hodnota podniku (EV) N/A
Tržby N/A
EBITDA N/A
Zisk -4.22
Růst v tržbách Q/Q -24.21 %
Růst v tržbách Y/Y -63.33 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 7.73
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 1.63
P/FCF N/A
Price/Book 6.59
Účetní hodnota na akcii 0.70
Hotovost na akcii N/A
FCF vůči ceně -9.74 %
Počet zaměstnanců 0
Tržba na zaměstnance N/A
Profit margin N/A %
Operating margin -57.50 %
Gross margin N/A %
EBIT margin -65.16 %
EBITDA margin -30.91 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 1,066.67 %
EPS - Očekávaný růst příští rok N/A %
Return on assets -14.90 %
Return on equity -68.71 %
ROIC -10.04 %
ROCE -70.42 %
Dluhy/Equity N/A
Čistý dluh/EBITDA 3.88
Current ratio 0.59
Quick Ratio 0.40
Volatilita 18.41
Beta 0.00
RSI 40.11
Cílová cena analytiků 3
Známka akcie (dle analytiků) N/A
Insider ownership 7.49 %
Institutional ownership 16.92 %
Počet akcií 7.785M
Procento shortovaných akcií 6.91 %
Short ratio 0.56 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie CGIX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$7.305$4.932$29.121$27.049$18.04$10.199
Cost Of Goods Sold$3.701$3.09$18.07$17.104$14.098$8.453
Gross Profit$3.604$1.842$11.051$9.945$3.942$1.746
Research And Development Expenses-$0.154$4.789$5.967$5.483$4.622
SG&A Expenses$6.317$7.913$24.884$20.702$19.836$16.333
Other Operating Income Or Expenses$-0.117$-1.464----
Operating Expenses$13.008$12.621$47.743$43.773$39.417$29.408
Operating Income$-5.703$-7.689$-18.622$-16.724$-21.377$-19.209
Total Non-Operating Income/Expense$-1.694$3.484$-4.337$0.921$0.009$0.216
Pre-Tax Income$-7.397$-4.205$-22.959$-15.803$-21.368$-18.993
Income Taxes$-0.512-$-2.079-$-1.184$-2.35
Income After Taxes$-6.885$-4.205$-20.88$-15.803$-20.184$-16.643
Other Income------
Income From Continuous Operations$-6.885$-4.205$-20.88$-15.803$-20.184$-16.643
Income From Discontinued Operations$0.177$-16.168----
Net Income$-6.708$-20.373$-20.88$-15.803$-20.184$-16.643
EBITDA$-1.576$-6.662$-15.158$-14.337$-19.707$-18.06
EBIT$-5.703$-7.689$-18.622$-16.724$-21.377$-19.209
Basic Shares Outstanding211100
Shares Outstanding211100
Basic EPS$-3.48$-22.39$-30.33$-30.03$-58.86$-52.85
EPS - Earnings Per Share$-3.48$-22.39$-30.33$-30.03$-58.86$-54.05
# 2020 2019 2018 2017 2016 2015
Current Ratio1.02950.86881.18162.12062.85847.2732
Long-term Debt / Capital0.01430.00790.02280.10570.12960.1542
Debt/Equity Ratio0.19660.37930.41220.20050.1930.184
Gross Margin49.336137.347937.948636.766621.851417.1193
Operating Margin-78.0698-155.9002-63.947-61.8285-118.4978-188.342
EBIT Margin-78.0698-155.9002-63.947-61.8285-118.4978-188.342
EBITDA Margin-21.5743-135.077-52.0518-53.0038-109.2406-177.0762
Pre-Tax Profit Margin-101.2594-85.2595-78.84-58.4236-118.4479-186.2241
Net Profit Margin-91.8275-413.0778-71.7008-58.4236-111.8847-163.1826
Asset Turnover0.49010.13930.55760.63740.3690.2165
Inventory Turnover Ratio------
Receiveable Turnover10.49576.34752.65752.30242.72472.0284
Days Sales In Receivables34.776257.503137.3466158.5279133.9615179.9411
ROE - Return On Equity-93.2294-61.8202-78.0123-61.6727-61.1321-48.1652
Return On Tangible Equity-491.7855167.5297-486.1466-130.6897-104.7921-53.9237
ROA - Return On Assets-46.1957-11.8765-39.9839-37.2414-41.2896-35.3317
ROI - Return On Investment-91.898-61.3331-76.235-55.155-53.2068-40.7378
Book Value Per Share3.517.361528.959940.636372.6268105.657
Operating Cash Flow Per Share9.30175.919514.08495.8544-0.494512.7013
Free Cash Flow Per Share9.30597.766913.14657.86590.92719.991